Loading Programs

« All Events

The Who, What, When & Why of Maintenance Therapy in Ovarian Cancer

September 1, 2020 - September 1, 2021

How have PARP inhibitors changed maintenance therapy for advanced ovarian cancer? Join Dr Michael Birrer and Dr Ursula Matulonis as they discuss recent clinical data related to the use of PARP inhibitors in maintenance therapy for advanced ovarian cancer, and highlight strategies to effectively prevent and manage treatment-related adverse effects.

This activity is jointly provided by Postgraduate Institute for Medicine and Spire Learning.
This activity is supported by an independent educational grant from Tesaro, a GSK company.

 

Click on this link to access the program:

https://www.mycme.com/courses/the-who-what-when-and-why-of-maintenance-therapy-in-ovarian-cancer-7254

Details

Start:
September 1
End:
September 1, 2021
Program Category:
Program Tags:
, ,

Organizer

Spire Learning
Phone:
(973) 605-2922
Email:
info@spirelearning.com
Website:
spirelearning.com

Other

Presenter
Michael Birrer, MD, PhD and Ursula Matulonis, MD

Details

Start:
September 1
End:
September 1, 2021
Program Category:
Program Tags:
, ,

Organizer

Spire Learning
Phone:
(973) 605-2922
Email:
info@spirelearning.com
Website:
spirelearning.com

Other

Presenter
Michael Birrer, MD, PhD and Ursula Matulonis, MD